HCA Healthcare Files Q2 2024 10-Q
Ticker: HCA · Form: 10-Q · Filed: Jul 29, 2024 · CIK: 860730
Sentiment: neutral
Topics: 10-Q, healthcare, financials
TL;DR
HCA Healthcare dropped its Q2 10-Q. Financials look solid.
AI Summary
HCA Healthcare, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the company, which operates general medical and surgical hospitals. Key financial data and disclosures relevant to investors and stakeholders are presented.
Why It Matters
This filing provides crucial financial and operational insights into HCA Healthcare's performance, impacting investor decisions and market perception of the healthcare sector.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Numbers
- 20240630 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 20240729 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- HCA Healthcare, Inc. (company) — Filer of the 10-Q
- 20240630 (date) — End of the reporting period
- 20240729 (date) — Date of filing
- Nashville, TN (location) — Company headquarters
FAQ
What is the primary business of HCA Healthcare, Inc.?
HCA Healthcare, Inc. operates general medical and surgical hospitals, as indicated by its Standard Industrial Classification code [8062].
What is the fiscal year end for HCA Healthcare, Inc.?
The fiscal year end for HCA Healthcare, Inc. is December 31st.
When was the company previously known as HCA Holdings, Inc.?
The company changed its name from HCA Holdings, Inc. on November 26, 2010.
What is the filing date of this 10-Q report?
This 10-Q report was filed on July 29, 2024.
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ending June 30, 2024.
Filing Stats: 4,559 words · 18 min read · ~15 pages · Grade level 11.4 · Accepted 2024-07-29 16:30:24
Filing Documents
- hca-20240630.htm (10-Q) — 2300KB
- hca-ex22.htm (EX-22) — 4KB
- hca-ex31_1.htm (EX-31.1) — 13KB
- hca-ex31_2.htm (EX-31.2) — 14KB
- hca-ex32.htm (EX-32) — 13KB
- 0000950170-24-087322.txt ( ) — 8187KB
- hca-20240630.xsd (EX-101.SCH) — 862KB
- hca-20240630_htm.xml (XML) — 1583KB
Financial Statements (Unaudited)
Financial Statements (Unaudited): Condensed Consolidated Income Statements — for the quarters and six months ended June 30, 2024 and 2023 3 Condensed Consolidated Comprehensive Income Statements — for the quarters and six months ended June 30, 2024 and 2023 4 Condensed Consolidated Balance Sheets — June 30, 2024 and December 31, 2023 5 Condensed Consolidated Statements of Stockholders' Equity (Deficit) — for the quarters and six months ended June 30, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows — for the six months ended June 30, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 28 Item 4.
Controls and Procedures
Controls and Procedures 28 Part II. Other Information Item 1.
Legal Proceedings
Legal Proceedings 28 Item 1A.
Risk Factors
Risk Factors 28 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28 Item 5. O Other Information 29 Item 6. Exhibits 29
Signatures
Signatures 30 2 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED INCOME STATEMENTS FOR THE QUARTERS AND SIX MONTHS ENDED JUNE 30, 2024 AND 2023 Unaudited (Dollars in millions, except per share amounts) Quarter Six Months 2024 2023 2024 2023 Revenues $ 17,492 $ 15,861 $ 34,831 $ 31,452 Salaries and benefits 7,685 7,277 15,392 14,361 Supplies 2,634 2,478 5,305 4,901 Other operating expenses 3,623 3,043 7,229 5,937 Equity in losses of affiliates — 7 2 25 Depreciation and amortization 819 763 1,614 1,519 Interest expense 506 485 1,018 964 Losses (gains) on sales of facilities ( 12 ) ( 1 ) ( 213 ) 14 15,255 14,052 30,347 27,721 Income before income taxes 2,237 1,809 4,484 3,731 Provision for income taxes 550 397 995 776 Net income 1,687 1,412 3,489 2,955 Net income attributable to noncontrolling interests 226 219 437 399 Net income attributable to HCA Healthcare, Inc. $ 1,461 $ 1,193 $ 3,052 $ 2,556 Per share data: Basic earnings $ 5.60 $ 4.35 $ 11.61 $ 9.27 Diluted earnings $ 5.53 $ 4.29 $ 11.47 $ 9.14 Shares used in earnings per share calculations (in millions): Basic 261.156 274.494 262.795 275.695 Diluted 264.071 278.198 266.044 279.573 The accompanying notes are an integral part of the condensed consolidated financial statements. 3 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS FOR THE QUARTERS AND SIX MONTHS ENDED JUNE 30, 2024 AND 2023 Unaudited (Dollars in millions) Quarter Six Months 2024 2023 2024 2023 Net income $ 1,687 $ 1,412 $ 3,489 $ 2,955 Other comprehensive income (loss) before taxes: Foreign currency translation 1 20 ( 7 ) 38 Unrealized (losses) gains on available-for-sale securities ( 1 ) ( 5 ) ( 3 ) 2 Other comp